Indian Generic Medicines (IGM) facilitates pharmaceutical contract manufacturing from India through WHO-GMP, US FDA, EU-GMP and PIC/S-accredited partner facilities — covering tablets, capsules, and sterile injectables across 20+ therapeutic categories, with complete regulatory dossier support for export markets in Asia, Africa, LATAM, the Middle East, and Europe.
Pharmaceutical Contract Manufacturing in India — Built for Global Compliance
Indian Generic Medicines (IGM) connects importers, distributors, and brand owners with certified Indian manufacturing facilities for third-party and private-label production of generic medicines. From formulation sourcing to batch release and export documentation, our team manages the process end to end — so your products reach regulated and semi-regulated markets on time and fully compliant.
Every project is executed through accredited partner plants, with transparent quality agreements, complete batch records, and regulatory dossiers (CTD/ACTD) prepared for your target market.
Partner Facility Accreditations
WHO-GMP
US FDA
EU-GMP
UK MHRA
PIC/S
EMAManufacturing is carried out at duly licensed and accredited partner facilities. Certifications apply to the respective manufacturing sites.
How Contract Manufacturing Works with IGM
Dosage Forms We Support
Therapeutic Categories
Contract manufacturing support is available across major therapy areas, including:
Why Choose Us as Your Contract Manufacturer in India?
We understand every client's unique needs and ensure that a customized product is manufactured as per your market requirements and therapeutic segment.
All manufacturing takes place in fully certified, WHO-GMP/US FDA/EU-GMP-compliant facilities that adhere to the highest standards of pharmaceutical production.
We coordinate complete contract manufacturing, packaging, batch release, and on-time delivery across a wide range of dosage forms — solid, liquid, semi-solid, and sterile.
Regulatory Coverage for Your Market
Through our network of certified manufacturers, we support products intended for markets governed by:
Frequently Asked Questions
Does IGM manufacture medicines itself?
No. IGM is a pharmaceutical trading and consultancy company. All manufacturing is carried out at duly licensed, accredited third-party facilities in India under formal quality agreements. IGM manages sourcing, coordination, documentation, and export.
What is the minimum order quantity (MOQ) for contract manufacturing?
MOQs vary by molecule, dosage form, and facility. Oral solids typically start at one commercial batch; injectables depend on line capacity. Share your requirement and we will confirm MOQs from matched facilities.
Can you support product registration in our country?
Yes. We provide CTD/ACTD dossiers, stability data, GMP certificates, and free-sale certificates as required by regulators across Asia, Africa, LATAM, the Middle East, and Europe.
Do you offer private-label (own brand) manufacturing?
Yes. Private-label and third-party manufacturing are both supported, including artwork adaptation, market-specific labelling, and serialization where applicable.
How long does a typical contract manufacturing project take?
After dossier and agreement finalisation, standard oral solid batches are typically produced within 45–90 days. Sterile and speciality products depend on facility scheduling; timelines are confirmed before agreement signing.
Start Your Contract Manufacturing Project
Tell us your molecule, dosage form, and target market — our team will respond with facility options, MOQs, and timelines.
Get in Touch
